Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyproline Metabolism to Oxalate in Primary Hyperoxaluria
NCT02038543Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2013
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Mayo Clinic. Primary endpoint: Mean Percent Conversion of Hydroxyproline to Urinary Oxalate at 24 hours. Started Sep 2013; status: completed.
Beyond the preview
Go deeper on NCT02038543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038543.